Search

Author/Creator Ghandehari, H.

1. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Issue 5 (May 2021)

Authors:
Yazici, Y.; McAlindon, T.E.; Gibofsky, A.; Lane, N.E.; Lattermann, C.; Skrepnik, N.; Swearingen, C.J.; Simsek, I.; Ghandehari, H.; DiFrancesco, A.; Gibbs, J.; Tambiah, J.R.S.; Hochberg, M.C.
Journal:
Osteoarthritis and cartilage
Issue:
Volume 29:Issue 5(2021)
Page Start:
654
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of a recombinant factor IX (Bax326)1 in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open‐label, uncontrolled, multicentre, phase III study. (3rd April 2014)

Authors:
Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Ghandehari, H.; Chapman, M.; Fritsch, S.; Wong, W.‐Y.; Pavlova, B. G.; Abbuehl, B. E.
Journal:
Haemophilia
Issue:
Volume 20:Number 5(2014:Sep.)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of a recombinant factor IX (Bax326)1 in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open‐label, uncontrolled, multicentre, phase III study. (3rd April 2014)

Authors:
Windyga, J.; Lissitchkov, T.; Stasyshyn, O.; Mamonov, V.; Ghandehari, H.; Chapman, M.; Fritsch, S.; Wong, W.‐Y.; Pavlova, B. G.; Abbuehl, B. E.
Journal:
Haemophilia
Issue:
Volume 20:Number 5(2014:Sep.)
Page Start:
651
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. OP0061 Treatment of knee osteoarthritis with sm04690 improved womac a1 'pain on walking' – results from a 52 week, randomised, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, wnt pathway inhibitor. (12th June 2018)

Authors:
Kennedy, S.; Ghandehari, H.; Swearingen, C.; Tambiah, J.; Hochberg, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗